GSK: stock down after quarterly results

(CercleFinance.com) - GSK (GlaxoSmithKline) is down over 3% in London today, after the healthcare group posted adjusted Q1 2018 EPS that is down 2% at 24.
6 pence, albeit up 11% at constant exchange rates.

The group's adjusted operating margin slipped 0.2 point to 26.6%, weighed on by currency fluctuations, for sales of 7.2 billion pounds, up 4% y-o-y at constant exchange rates.

For 2018, GSK maintains its forecast of adjusted EPS growth of 4%-7% excluding FX factors and in the absence of a generic competitor for its Advair drug in the US mid-year (a fall of up to -3% otherwise).


Copyright (c) 2018 CercleFinance.com. All rights reserved.